Exicure (XCUR) Cash from Financing Activities (2016 - 2025)
Exicure (XCUR) reported Cash from Financing Activities of $1.6 million for Q1 2025, down 87.1% quarter-over-quarter from $12.4 million in Q4 2024.
Exicure (XCUR) Cash from Financing Activities (2016 - 2025) Analysis & Trends
Exicure has reported Cash from Financing Activities for 10 years, with the latest figure at $1.6 million in Q1 2025.
- For the quarter ending Q1 2025, Cash from Financing Activities changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (down 88.06% YoY), and the FY2025 full-year result was $1.6 million, down 88.06% from the prior year.
- Cash from Financing Activities for Q1 2025 stood at $1.6 million, down from $12.4 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $12.4 million in Q4 2024, with the low at -$8.0 million in Q1 2022.
- Historically, Cash from Financing Activities has averaged $1.2 million across 5 years, with a median of $289500.0 in 2021.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 1563.92% — and 2024, when it surged 1240300.0%.
- Exicure's Cash from Financing Activities stood at $448000.0 in 2021, then plunged by 100.45% to -$2000.0 in 2022, then jumped by 50.0% to -$1000.0 in 2023, then surged by 1240300.0% to $12.4 million in 2024, then slumped by 87.1% to $1.6 million in 2025.
- The last three Cash from Financing Activities figures came in at $1.6 million (Q1 2025), $12.4 million (Q4 2024), and $1.0 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 85,464.43 |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 12.40 Mn |
| Dec 31, 2024 | 12.40 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -919,000.00 |
| Jun 30, 2023 | -919,000.00 |
| Mar 31, 2023 | 4.60 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | 4.89 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | -7.99 Mn |
| Mar 31, 2022 | -7.99 Mn |